Article
Laser-assisted procedure brings ease, precision, safety to deep sclerectomy
CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.
TAKE HOME:
CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.
By Cheryl Guttman Krader; Reviewd by Svetlana Anisimova, MD, PhD
Moscow-CO2 laser-assisted sclerectomy surgery (CLASS) performed with a proprietary platform (IOPtiMate System, IOPtima) is a non-penetrating procedure for management of medically uncontrolled open-angle glaucoma that offers efficacy comparable to trabeculectomy and non-penetrating deep sclerectomy (NPDS), but with superior safety, according to Prof. Svetlana Anisimova, MD, PhD.
Dr. Anisimova has been a pioneer in the development of NPDS and explained that by implementing use of the laser for dissecting the scleral flap, CLASS overcomes the major challenge of NPDS, which is the risk of inadvertent trabeculo-Descemet’s membrane perforation.
Because the wavelength of the CO2 laser is absorbed by water, the device’s cutting effect is halted when the dissection reaches the desired endpoint of fluid percolation.
In addition, the laser-assisted procedure and features of the proprietary platform simplify the surgery, further reducing the prolonged learning curve characteristic of manual NPDS, said Dr. Anismova, general director, EYE Center “Vostok-Prozrenie, Moscow, Russia.
“NPDS has a better safety profile than trabeculectomy, but technical difficulty is one of the main drawbacks of NPDS,” she said. “In the hands of surgeons new to NPDS performing manual dissection with a knife, there is a high rate of penetration, which leads to the same complications as after trabeculectomy. And, if the dissection doesn’t open the entire width of trabecular, effective filtration may not be achieved.”
CLASS transforms deep sclerectomy into safe, convenient, elegant and precise laser-assisted surgery that can be performed confidently by surgeons with a wide range of experience in filtration surgery. With CLASS, the microdissection is controlled and performed under direct microscopic observation.
“In addition, surgeons do not need to manually dissect layers of sclera and the drainage system or locate the orifice of the Schlemm’s canal as they do in manual NPDS techniques, she said.
Surgical outcomes
The CO2 laser can be integrated with any ophthalmic microscope, and the novel laser-assisted platform that is used for CLASS features a micro-manipulating scanner that guides the laser beam, assuring that the sclera is accurately ablated per the pre-selected area and pattern.
Dr. Anisiomova began performing CLASS in June 2009, and has data on 9 eyes with follow-up to 5 years.
Mean (± SD) IOP was 27.3 ± 4.8 mm Hg preoperatively, 17.4 ± 2.4 mm Hg at 6 months, 18.3 ± 2.1 mm Hg at 12 months, and 17.5 ± 1.5 mm at 5 years of follow-up (6 patients were examined 5 years after surgery).
Medication use per patient decreased from an average of 2.5 ± 1.5 preoperatively to 0.5 ± 0.4 at 6 months and 1.6 ± 0.9 at 5 years after surgery.
Additional procedures performed in the series included YAG laser goniopuncture, carried out 4 to 10 weeks after the initial surgery in 2 eyes, and combined surgery (NPDS with phacoemulsification) in 1 eye at 4 years after the CLASS procedure.
“Goniopuncture was not considered a reason for failure or an adverse event as it is commonly used after other glaucoma surgeries to maintain or augment the operative results,” Dr. Anisimova said.
The recorded complications were mostly mild and transitory. There were some microperforations, but no macroperforations.
“The microperforations did not affect the safety or efficacy of the surgical outcome and might even have improved filtration,” Dr. Anisimova said.
Data from 3 years of follow-up in a multicenter study of CLASS show its safety benefits relative to trabeculectomy. The multicenter study included 108 CLASS procedures and their outcomes were compared with a historical control cohort of 105 eyes that underwent trabeculectomy. CLASS was associated with 36% fewer complications (50% versus 86.7%), 33% less vision loss, and 39% fewer cases of cataract development.
Svetlana Anisimova, MD, PhD
Dr. Anisimova has no relevant financial interest to disclose.
